These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9463809)

  • 1. Preparation and characterization of sustained-release microspheres of chlorpromazine.
    Gao ZG; Oh KH; Kim CK
    J Microencapsul; 1998; 15(1):75-83. PubMed ID: 9463809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
    Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of buoyant theophylline microspheres with near zero order release kinetics.
    Stithit S; Chen W; Price JC
    J Microencapsul; 1998; 15(6):725-37. PubMed ID: 9818950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of some formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres.
    El-Bary AA; Aboelwafa AA; Al Sharabi IM
    AAPS PharmSciTech; 2012 Mar; 13(1):75-84. PubMed ID: 22130789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
    Singh V; Chaudhary AK
    Acta Pol Pharm; 2011; 68(6):975-80. PubMed ID: 22125964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of novel polymeric microspheres for controlled release of finasteride.
    Peng D; Huang K; Liu Y; Liu S
    Int J Pharm; 2007 Sep; 342(1-2):82-6. PubMed ID: 17580108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of eudragit RS microspheres.
    iHoroz BB; Kliçarslan M; Yüksel N; Baykara T
    AAPS PharmSciTech; 2006 Feb; 7(1):E16. PubMed ID: 16584146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microspheres with pH modulated release: design and characterization of formulation variables for colonic delivery.
    Chandran S; Sanjay KS; Ali Asghar LF
    J Microencapsul; 2009 Aug; 26(5):420-31. PubMed ID: 18821120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method.
    Kim BK; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2002; 19(6):811-22. PubMed ID: 12569029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in-vitro evaluation of sustained-release metoclopramide hydrochloride microspheres.
    Khidr SH; Niazy EM; el-Sayed YM
    J Microencapsul; 1995; 12(6):651-60. PubMed ID: 8558387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive release of indomethacin using lactan-acetate microspheres.
    Na K; Lee KY
    Drug Dev Ind Pharm; 1998 Jun; 24(6):563-8. PubMed ID: 9876624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.